Dr. Kim is the Director of the Interstitial Lung Disease program and supervises ILD clinical trials. She established the University of Minnesota ILD database in 2010 to answer questions about natural history and outcomes of ILD. She led the ILD program to achieve recognition as a Pulmonary Fibrosis Foundation Care Center Network site, which identifies pulmonary fibrosis centers that provide leading clinical care and research. She also organizes the University of Minnesota Pulmonary Fibrosis Patient Education Day, a biennial free symposium for patients and families with pulmonary fibrosis that provides the latest updates in pulmonary fibrosis care and research. Her clinical expertise centers on treating patients with interstitial lung disease, including idiopathic pulmonary fibrosis, chronic hypersensitivity pneumonitis, IgG4-related lung disease, airway-centered interstitial fibrosis, scleroderma lung disease, other connective tissue disease-related lung diseases, and rare ILDs. Her research interests include natural history and outcomes in idiopathic pulmonary fibrosis, pharmacogenomics of anti-fibrotic medications, non-pharmacologic treatments for ILDs, and clinical trials in ILD.